BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22114830)

  • 1. The relationship between serum 25(OH)D and parathyroid hormone levels.
    Saliba W; Barnett O; Rennert HS; Lavi I; Rennert G
    Am J Med; 2011 Dec; 124(12):1165-70. PubMed ID: 22114830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D insufficiency in a population of healthy western Canadians.
    Rucker D; Allan JA; Fick GH; Hanley DA
    CMAJ; 2002 Jun; 166(12):1517-24. PubMed ID: 12074117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
    Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
    J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.
    Kinyamu HK; Gallagher JC; Petranick KM; Ryschon KL
    J Bone Miner Res; 1996 Oct; 11(10):1400-5. PubMed ID: 8889838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake.
    Adami S; Viapiana O; Gatti D; Idolazzi L; Rossini M
    Bone; 2008 Feb; 42(2):267-70. PubMed ID: 18024243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
    Fisher L; Fisher A
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calciotropic hormones and bone markers in the elderly.
    Gallagher JC; Kinyamu HK; Fowler SE; Dawson-Hughes B; Dalsky GP; Sherman SS
    J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of calcitriol and parathyroid hormone on serum aluminum in vitamin D-depleted rabbits fed an aluminum-supplemented diet.
    Long JF; Nagode LA; Steinmeyer CL; Renkes G
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):3-14. PubMed ID: 8165367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women.
    Krall EA; Sahyoun N; Tannenbaum S; Dallal GE; Dawson-Hughes B
    N Engl J Med; 1989 Dec; 321(26):1777-83. PubMed ID: 2594036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D status in primary hyperparathyroidism.
    Saliba W; Lavi I; Rennert HS; Rennert G
    Eur J Intern Med; 2012 Jan; 23(1):88-92. PubMed ID: 22153538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
    Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
    Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB
    N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.